BIOMAT Database Logo BIOMAT Database Logo

Use of Guanabenz in hypertension. 1981

G Hasking, and T Morgan, and J Myers

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D010869 Pindolol A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638) Prindolol,LB-46,Visken,LB 46,LB46
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive

Related Publications

G Hasking, and T Morgan, and J Myers
[Guanabenz in primary hypertension].
March 1988, Revista medica de Chile,
G Hasking, and T Morgan, and J Myers
Guanabenz in essential hypertension.
March 1977, Clinical pharmacology and therapeutics,
G Hasking, and T Morgan, and J Myers
Guanabenz for adolescent hypertension.
January 1984, Pediatric pharmacology (New York, N.Y.),
G Hasking, and T Morgan, and J Myers
Effects of guanabenz in adolescent hypertension.
January 1984, Journal of cardiovascular pharmacology,
G Hasking, and T Morgan, and J Myers
[Guanabenz in hypertension in the aged].
May 1984, Minerva cardioangiologica,
G Hasking, and T Morgan, and J Myers
Use of guanabenz in methadone withdrawal.
September 1985, The American journal of psychiatry,
G Hasking, and T Morgan, and J Myers
[Treatment of idiopathic hypertension with guanabenz-mefruside].
May 1984, Minerva cardioangiologica,
G Hasking, and T Morgan, and J Myers
Long-term therapy of hypertension with guanabenz.
January 1981, Clinical therapeutics,
G Hasking, and T Morgan, and J Myers
Disposition of 14C-guanabenz in patients with essential hypertension.
January 1980, Clinical pharmacology and therapeutics,
G Hasking, and T Morgan, and J Myers
Evaluation of guanabenz added to hydrochlorothiazide therapy in hypertension.
January 1982, The Journal of international medical research,
Copied contents to your clipboard!